// Biotech and Pharma Therapeutics
Currax Pharmaceuticals Hosted Ribbon-Cutting Ceremony to Mark the Opening of its Nashville Headquarters
Currax Pharmaceuticals, LLC (“Currax”), a specialty biopharmaceutical company dedicated to expanding access to clinically differentiated, underappreciated medicines – both branded and generic – hosted a grand opening celebration of its new headquarters on September 29, 2021. Brentwood Mayor Rhea Lit…
Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals
Takeda and JCR announced an exclusive collaboration and license agreement to commercialize JR-141 for the treatment of Hunter syndrome.
U.S. FDA approves AbbVie’s migraine prevention drug
AbbVie Inc said on Tuesday the U.S. health regulator approved its once-daily oral medicine for preventive treatment of migraine in adults, adding a third drug to the drugmaker’s arsenal of therapies for severe headaches.
Canadian startup Gini Health launches new product aimed at ‘reversing diabetes’
The program was tested in a 12-week pilot study that provided “promising evidence” that Type 2 diabetes can be reversed.
Dexcom finds CGM use helps people with Type 2 diabetes stay in range - MedCity News
The company recently published new results on its MOBILE study, which found that CGM use increased time in range for people with Type 2 diabetes. New data shows people who stopped using a CGM saw time in range decrease.
// 4th Industrial Revolution
Japanese pharmaceutical firm taps Israel’s CytoReason for AI drug development
Tel Aviv-based startup uses machine learning to build computational models of human immune system and diseases to speed up treatments.
Blockchain and the Pharmaceutical Industry | Technology | Manufacturing Global
Blockchain - an open, decentralised, secure, public ledger that stores every single record, event, or transaction sequentially in a verifiable way, as ‘blocks’. Each ‘block’ has a timestamp and is linked to a previous block which is added to the existing blockchain when the majority of users validate its authenticity. Once added, it cannot be altered or deleted and is visible to all participants.
Study: Wearables could detect flu, cold infection before patient shows symptoms
A prediction model that used wearable data was able to detect pre-symptomatic H1N1 and rhinovirus.
Bioprinted Brain Cells Made Possible with Laser-Based 3D Printing - 3DPrint.com | The Voice of 3D Printing / Additive Manufacturing
Scientists from the Université de Montréal have published a study detailing the ability to bioprint adult brain cells. Key to the research was a new laser-assisted technology that made it...
// Business & Markets
FourKites Named a Leader in Pharmaceutical Supply Chain Visibility Report
Cardinal Health, Bayer, 3M and other pharmaceutical leaders increasingly turn to FourKites for end-to-end supply chain visibility FourKites Named a Leader in Pharmaceutical Supply Chain Visibility Report Cardinal Health, Bayer, 3M and other pharmaceutical leaders increasingly turn to FourKites for e…
Cedars-Sinai Accelerator selects 8 new health tech startups - MedCity News
The seventh accelerator class includes startups with a range of offerings, from accessible fitness for aging patients to skeletal reconstruction. Each of the eight companies will receive $100,000 and access to clinicians, researchers and administrators to develop their products and grow their busine…
Digital surgery company Activ Surgery scores $45M, end-of-life platform Empathy bags $30M and other digital health fundings
Activ Surgical, a Boston-based digital surgery startup, announced a $45 million Series B funding round today. Cota Capital led the round along with new investors BAM Funds, Magnetar Capital, Mint Ventures, Castor Ventures, Dream One Vision and NVIDIA.
// Legal & Regulatory
Euro Roundup: Commission seeks feedback on pharmaceutical legislation reform
The European Commission is seeking feedback on planned reforms intended to address problems such as the “inefficiency and administrative burden of regulatory procedures.”
Another Eisai, Biogen Alzheimer’s drug is filed for speedy FDA review - MedCity News
Eisai is seeking accelerated FDA approval of lecanemab, an Alzheimer’s disease drug that is part of a research alliance with Biogen. The drug is following the same path blazed earlier this year with FDA approval of Biogen Alzheimer’s drug Aduhelm.
Delix Therapeutics Pursues A Psychedelic-Inspired Medicine Without The Trip
The Boston-based neuroscience startup raised $70 million to turn its patented molecules based on classic psychedelic drugs into medicine.
// Research & Development
U.S. FDA Placed a Clinical Hold on BMN 307 Phearless Phase 1/2 Gene Therapy Study in Adults with PKU Based on Interim Pre-clinical Study Findings
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the U.S Food and Drug Administration (FDA) placed a clinical hold on the BMN 307 Phearless Phase 1/2 study.
Biohaven’s neurological disorder drug candidate fails study
Biohaven Pharmaceutical Holding Co Ltd said on Monday its drug candidate, verdiperstat, failed to show effectiveness in treating a rare neurological disorder called multiple system atrophy (MSA).
Pfizer begins study of oral drug for prevention of COVID-19
Pfizer Inc said on Monday it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus.
GSK, Merck KGaA end cancer drug partnership after study results disappoint
Bintrafusp alfa was highlighted by GSK as a potential blockbuster drug as recently as January. Negative findings in two trials, however, led the companies to unwind their research collaboration.
Researchers unravel the genetic cause of a childhood disorder and a potential way to prevent it with drugs
A UCSD-led team reported a potential way to prevent a newly discovered genetic condition called Zaki syndrome, which impacts the prenatal development of the eyes, brain, hands, kidneys and heart. The researchers found that children born with Zaki had genetic mutations that, in preclinical models, co…
DoD watchdog criticizes oversight of military’s pharmaceutical supply chain
Addressing the U.S. pharmaceutical supply chain would “mitigate public health and national security risks,” officials said in a new report.
The U.S. Can Lower Drug Prices Without Sacrificing Innovation
Large pharmaceutical companies are nowhere near as important to real drug innovation as they purport to be.
What the Stalemate on Capitol Hill Means for Your Drug Prices
Despite big 2020 campaign promises to deliver lower costs on prescription drugs, Democrats have failed to unite around a legislative plan.